EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ

Vittoria Matafora, Alena Gorb, Fangjia Yang, Wendy Noble iD, Angela Bachi iD, Beatriz Gomez Perez-Nievas iD, Maria Jimenez-Sanchez iD

Journal of Neurochemistry · 2023

DOI: 10.1111/jnc.15875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2023. Verfasst von Vittoria Matafora und 6 weiteren Autor:innen. Beteiligte Einrichtung: IFOM ETS- The AIRC Institute of Molecular Oncology, Milan, Italy. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocytes associate with amyloid plaques in Alzheimer's disease (AD). Astrocytes react to changes in the brain environment, including increasing concentrations of amyloid‐β (Aβ). However, the precise response of astrocytes to soluble small Aβ oligomers at concentrations similar to those present in the human brain has not been addressed. In this study, we exposed astrocytes to media from neurons that express the human amyloid precursor protein ( APP) transgene with the double Swedish mutation (APPSwe), and which contains APP‐derived fragments, including soluble human Aβ oligomers. We then used proteomics to investigate changes in the astrocyte secretome. Our data show dysregulated secretion of astrocytic proteins involved in the extracellular matrix and cytoskeletal organization and increase secretion of proteins involved in oxidative stress responses and those with chaperone activity. Several of these proteins have been identified in previous transcriptomic and proteomic studies using brain tissue from human AD and cerebrospinal fluid (CSF). Our work highlights the relevance of studying astrocyte secretion to understand the brain response to AD pathology and the potential use of these proteins as biomarkers for the disease. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAlzheimer DiseaseHumansProteomicsSecretomeAmyloid beta-PeptidesAmyloid beta-Protein Precursor

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • IFOM ETS- The AIRC Institute of Molecular Oncology, Milan, Italy.
  • Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

ORCID-Profile: Wendy Noble, Angela Bachi, Beatriz Gomez Perez-Nievas, Maria Jimenez-Sanchez

Förderung

  • Medical Research Council

Zitieren

APA

Matafora, V., Gorb, A., Yang, F., Noble, W., Bachi, A., Perez-Nievas, B. G., & Jimenez-Sanchez, M. (2023). Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15875

Vancouver

Matafora V, Gorb A, Yang F, Noble W, Bachi A, Perez-Nievas BG, et al. Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ. Journal of Neurochemistry. 2023. doi:10.1111/jnc.15875

BibTeX
@article{Matafora2023,
  author = {Matafora, Vittoria and Gorb, Alena and Yang, Fangjia and Noble, Wendy and Bachi, Angela and Perez-Nievas, Beatriz Gomez and Jimenez-Sanchez, Maria},
  title = {Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ},
  journal = {Journal of Neurochemistry},
  year = {2023},
  doi = {10.1111/jnc.15875}
}
Kostenlos starten →